These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 31603898)

  • 1. Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).
    Timp JF; Braekkan SK; Lijfering WM; van Hylckama Vlieg A; Hansen JB; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2019 Oct; 16(10):e1002883. PubMed ID: 31603898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Venous Thrombosis Risk after Cast Immobilization of the Lower Extremity: Derivation and Validation of a Clinical Prediction Score, L-TRiP(cast), in Three Population-Based Case-Control Studies.
    Nemeth B; van Adrichem RA; van Hylckama Vlieg A; Bucciarelli P; Martinelli I; Baglin T; Rosendaal FR; le Cessie S; Cannegieter SC
    PLoS Med; 2015 Nov; 12(11):e1001899; discussion e1001899. PubMed ID: 26554832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
    Timp JF; Lijfering WM; Rosendaal FR; le Cessie S; Cannegieter SC
    J Thromb Haemost; 2019 Sep; 17(9):1527-1534. PubMed ID: 31188515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of recurrent venous thromboembolism in patients with HIV infection: A nationwide cohort study.
    Rokx C; Borjas Howard JF; Smit C; Wit FW; Pieterman ED; Reiss P; Cannegieter SC; Lijfering WM; Meijer K; Bierman W; Tichelaar V; Rijnders BJA;
    PLoS Med; 2020 May; 17(5):e1003101. PubMed ID: 32407386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-dimer at venous thrombosis diagnosis is associated with risk of recurrence.
    Bjøri E; Johnsen HS; Hansen JB; Braekkan SK
    J Thromb Haemost; 2017 May; 15(5):917-924. PubMed ID: 28166605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of tailoring anticoagulant treatment duration by applying a recurrence risk prediction model in patients with venous thromboembolism compared to usual care: A randomized controlled trial.
    Geersing GJ; Hendriksen JMT; Zuithoff NPA; Roes KC; Oudega R; Takada T; Schutgens REG; Moons KGM
    PLoS Med; 2020 Jun; 17(6):e1003142. PubMed ID: 32589630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of the DASH prediction rule: a retrospective cohort study.
    Tosetto A; Testa S; Martinelli I; Poli D; Cosmi B; Lodigiani C; Ageno W; De Stefano V; Falanga A; Nichele I; Paoletti O; Bucciarelli P; Antonucci E; Legnani C; Banfi E; Dentali F; Bartolomei F; Barcella L; Palareti G
    J Thromb Haemost; 2017 Oct; 15(10):1963-1970. PubMed ID: 28762665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of risk of recurrence of venous thromboembolism following treatment for a first unprovoked venous thromboembolism: systematic review, prognostic model and clinical decision rule, and economic evaluation.
    Ensor J; Riley RD; Jowett S; Monahan M; Snell KIe; Bayliss S; Moore D; Fitzmaurice D;
    Health Technol Assess; 2016 Feb; 20(12):i-xxxiii, 1-190. PubMed ID: 26879848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between anticoagulant treatment duration and risk of venous thromboembolism recurrence and bleeding in clinical practice.
    Kaatz S; Fu AC; AbuDagga A; LaMori J; Bookhart BK; Damaraju CV; Tan H; Schein J; Nutescu E
    Thromb Res; 2014 Oct; 134(4):807-13. PubMed ID: 25127013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study.
    Timp JF; Lijfering WM; Flinterman LE; van Hylckama Vlieg A; le Cessie S; Rosendaal FR; Cannegieter SC
    J Thromb Haemost; 2015 Oct; 13(10):1823-32. PubMed ID: 26270389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid levels and risk of recurrent venous thrombosis: results from the MEGA follow-up study.
    Morelli VM; Lijfering WM; Rosendaal FR; Cannegieter SC
    J Thromb Haemost; 2017 Apr; 15(4):695-701. PubMed ID: 28135040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic variations associated with recurrent venous thrombosis.
    van Hylckama Vlieg A; Flinterman LE; Bare LA; Cannegieter SC; Reitsma PH; Arellano AR; Tong CH; Devlin JJ; Rosendaal FR
    Circ Cardiovasc Genet; 2014 Dec; 7(6):806-13. PubMed ID: 25210051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
    Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
    BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A risk score for prediction of recurrence in patients with unprovoked venous thromboembolism (DAMOVES).
    Franco Moreno AI; García Navarro MJ; Ortiz Sánchez J; Martín Díaz RM; Madroñal Cerezo E; de Ancos Aracil CL; Cabello Clotet N; Perales Fraile I; Gimeno García S; Montero Hernández C; Zapatero Gaviria A; Ruiz Giardín JM
    Eur J Intern Med; 2016 Apr; 29():59-64. PubMed ID: 26775136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual vein thrombosis and serial D-dimer for the long-term management of patients with deep venous thrombosis.
    Prandoni P; Vedovetto V; Ciammaichella M; Bucherini E; Corradini S; Enea I; Cosmi B; Mumoli N; Visonà A; Barillari G; Bova C; Quintavalla R; Zanatta N; Pedrini S; Villalta S; Camporese G; Testa S; Parisi R; Becattini C; Cuppini S; Pengo V; Palareti G;
    Thromb Res; 2017 Jun; 154():35-41. PubMed ID: 28407492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model.
    Eichinger S; Heinze G; Jandeck LM; Kyrle PA
    Circulation; 2010 Apr; 121(14):1630-6. PubMed ID: 20351233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow-up study.
    Sokol J; Timp JF; le Cessie S; van Hylckama-Vlieg A; Rosendaal FR; Kubisz P; Cannegieter SC; Lijfering WM
    J Thromb Haemost; 2018 Apr; 16(4):680-688. PubMed ID: 29377625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten years of cerebral venous thrombosis: male gender and myeloproliferative neoplasm is associated with thrombotic recurrence in unprovoked events.
    Lim HY; Ng C; Donnan G; Nandurkar H; Ho P
    J Thromb Thrombolysis; 2016 Oct; 42(3):423-31. PubMed ID: 27085541
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
    Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
    Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
    Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
    Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.